{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:00:00Z","timestamp":1789610400251,"version":"build-2803163510"},"reference-count":106,"publisher":"Elsevier","isbn-type":[{"value":"9780128002827","type":"print"}],"license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014]]},"DOI":"10.1016\/bs.apha.2014.06.003","type":"book-chapter","created":{"date-parts":[[2014,8,22]],"date-time":"2014-08-22T10:27:00Z","timestamp":1408703220000},"page":"245-275","source":"Crossref","is-referenced-by-count":23,"title":["Delivery of Antihuman African Trypanosomiasis Drugs Across the Blood\u2013Brain and Blood\u2013CSF Barriers"],"prefix":"10.1016","author":[{"given":"Gayathri N.","family":"Sekhar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher P.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet","family":"Fidanboylu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Sanderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah A.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/bs.apha.2014.06.003_bb0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.nbd.2009.07.030","article-title":"Structure and function of the blood-brain barrier","volume":"37","author":"Abbott","year":"2010","journal-title":"Neurobiology of Disease"},{"issue":"5922","key":"10.1016\/bs.apha.2014.06.003_bb0010","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1126\/science.1168750","article-title":"Structure of P-glycoprotein reveals a molecular basis for poly-specific drug binding","volume":"323","author":"Aller","year":"2009","journal-title":"Science"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.003_bb0015","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.molbiopara.2010.11.010","article-title":"Genome-wide RNAi screens in African trypanosomes identify the nifurtimox activator NTR and the eflornithine transporter AAT6","volume":"176","author":"Baker","year":"2011","journal-title":"Molecular and Biochemical Parasitology"},{"issue":"10","key":"10.1016\/bs.apha.2014.06.003_bb0020","doi-asserted-by":"crossref","first-page":"783","DOI":"10.2471\/BLT.06.031955","article-title":"Melarsoprol versus eflornithine for treating late-stage Gambian trypanosomiasis in the republic of the Congo","volume":"84","author":"Balasegaram","year":"2006","journal-title":"Bulletin of the World Health Organization"},{"issue":"3","key":"10.1016\/bs.apha.2014.06.003_bb0025","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.trstmh.2008.09.005","article-title":"Effectiveness of melarsoprol and eflornithine as first-line regimens for gambiense sleeping sickness in nine m\u00e9decins sans fronti\u00e8res programmes","volume":"103","author":"Balasegaram","year":"2009","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"8","key":"10.1016\/bs.apha.2014.06.003_bb0030","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.bjp.0707354","article-title":"Human African trypanosomiasis: Pharmacological re-engagement with a neglected disease","volume":"152","author":"Barrett","year":"2007","journal-title":"British Journal of Pharmacology"},{"issue":"5","key":"10.1016\/bs.apha.2014.06.003_bb0035","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s004360050274","article-title":"Altered transport properties of pentamidine-resistant leishmania donovani and L. amazonensis promastigotes","volume":"83","author":"Basselin","year":"1997","journal-title":"Parasitology Research"},{"issue":"3","key":"10.1016\/bs.apha.2014.06.003_bb0040","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0166-6851(87)90086-7","article-title":"Biochemical changes associated with a-difluoromethylornithine uptake and resistance in Trypanosoma brucei","volume":"25","author":"Bellofatto","year":"1987","journal-title":"Molecular and Biochemical Parasitology"},{"issue":"3","key":"10.1016\/bs.apha.2014.06.003_bb0045","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1042\/bj2960759","article-title":"A calmodulin-stimulated Ca2+ pump in plasma-membrane vesicles from Trypanosoma brucei; selective inhibition by pentamidine","volume":"296","author":"Benaim","year":"1993","journal-title":"Biochemical Journal"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.003_bb0050","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0166-6851(01)00208-0","article-title":"A receptor-like flagellar pocket glycoprotein specific to Trypanosoma brucei gambiense","volume":"113","author":"Berberof","year":"2001","journal-title":"Molecular and Biochemical Parasitology"},{"issue":"5733","key":"10.1016\/bs.apha.2014.06.003_bb0055","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1126\/science.1112642","article-title":"The genome of the African trypanosome Trypanosoma brucei","volume":"309","author":"Berriman","year":"2005","journal-title":"Science"},{"issue":"6","key":"10.1016\/bs.apha.2014.06.003_bb0060","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s10096-011-1403-y","article-title":"Human African trypanosomiasis in endemic populations and travellers","volume":"31","author":"Blum","year":"2012","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"issue":"2","key":"10.1016\/bs.apha.2014.06.003_bb0065","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1046\/j.1472-8206.2003.00167.x","article-title":"Treatment perspectives for human African trypanosomiasis","volume":"17","author":"Bouteille","year":"2003","journal-title":"Fundamental and Clinical Pharmacology"},{"issue":"9709","key":"10.1016\/bs.apha.2014.06.003_bb0070","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0140-6736(09)60829-1","article-title":"Human African trypanosomiasis","volume":"375","author":"Brun","year":"2010","journal-title":"The Lancet"},{"issue":"Suppl. 1","key":"10.1016\/bs.apha.2014.06.003_bb0075","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1007\/s00436-002-0766-5","article-title":"Eflornithine for the treatment of human African trypanosomiasis","volume":"90","author":"Burri","year":"2003","journal-title":"Parasitology Research"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.003_bb0080","first-page":"8","article-title":"Trypanosome prereplication machinery: A potential new target for an old problem","volume":"2011","author":"Calderano","year":"2011","journal-title":"Enzyme Research"},{"issue":"4","key":"10.1016\/bs.apha.2014.06.003_bb0085","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1021\/mp900178j","article-title":"ABC and SLC transporter expression and pot substrate characterization across the human CMEC\/D3 blood-brain barrier cell line","volume":"7","author":"Carl","year":"2010","journal-title":"Molecular Pharmaceutics"},{"issue":"12","key":"10.1016\/bs.apha.2014.06.003_bb0090","doi-asserted-by":"crossref","first-page":"e303","DOI":"10.1371\/journal.pntd.0000303","article-title":"The natural progression of gambiense sleeping sickness: What is the evidence?","volume":"2","author":"Checchi","year":"2008","journal-title":"PLoS Neglected Tropical Diseases"},{"key":"10.1016\/bs.apha.2014.06.003_bb0095","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2334-8-16","article-title":"Estimates of the duration of the early and late stage of gambiense sleeping sickness","volume":"8","author":"Checchi","year":"2008","journal-title":"BMC Infectious Diseases"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.003_bb0100","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11908-005-0024-y","article-title":"African trypanosomiasis: Changing epidemiology and consequences","volume":"7","author":"Chretien","year":"2005","journal-title":"Current Infectious Disease Reports"},{"issue":"6","key":"10.1016\/bs.apha.2014.06.003_bb0105","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.4269\/ajtmh.1984.33.1073","article-title":"New drug combination for experimental late-stage African trypanosomiasis: DL-a-difluoromethylornithine (DFMO) with suramin","volume":"33","author":"Clarkson","year":"1984","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"5","key":"10.1016\/bs.apha.2014.06.003_bb0110","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1055\/s-0031-1296205","article-title":"Mono-, di- and trisubstituted derivatives of eflornithine: Synthesis for in vivo delivery of DL-a-difluoromethylornithine in plasma","volume":"61","author":"Cloete","year":"2011","journal-title":"Arzneimittelforschung"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.003_bb0115","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0166-6851(97)00186-2","article-title":"Regulation of vsg expression site transcription and switching in Trypanosoma brucei","volume":"91","author":"Cross","year":"1998","journal-title":"Molecular and Biochemical Parasitology"},{"issue":"2","key":"10.1016\/bs.apha.2014.06.003_bb0120","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1550-7408.1976.tb03787.x","article-title":"Pentamidine transport and sensitivity in brucei group trypanosomes","volume":"23","author":"Damper","year":"1976","journal-title":"Journal of Protozoology"},{"issue":"3","key":"10.1016\/bs.apha.2014.06.003_bb0125","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0006-2952(76)90213-6","article-title":"Pentamidine transport in Trypanosoma brucei: Kinetics and specificity","volume":"25","author":"Damper","year":"1976","journal-title":"Biochemical Pharmacology"},{"issue":"2","key":"10.1016\/bs.apha.2014.06.003_bb0130","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0166-6851(94)90172-4","article-title":"The serum resistance-associated (SRA) gene of Trypanosoma brucei rhodesiense encodes a variant surface glycoprotein-like protein","volume":"68","author":"De Greef","year":"1994","journal-title":"Molecular and Biochemical Parasitology"},{"issue":"5\u20136","key":"10.1016\/bs.apha.2014.06.003_bb0135","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S0020-7519(01)00167-9","article-title":"Transporters in African trypanosomes: Role in drug action and resistance","volume":"31","author":"de Koning","year":"2001","journal-title":"International Journal for Parasitology"},{"issue":"3","key":"10.1016\/bs.apha.2014.06.003_bb0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0001-706X(01)00177-2","article-title":"Uptake of pentamidine in Trypanosoma brucei brucei is mediated by the P2 adenosine transporter and at least one novel, unrelated transporter","volume":"80","author":"de Koning","year":"2001","journal-title":"Acta Tropica"},{"issue":"7","key":"10.1016\/bs.apha.2014.06.003_bb0145","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1101\/gr.GR-1649R","article-title":"The human ATP-binding cassette (ABC) transporter superfamily","volume":"11","author":"Dean","year":"2001","journal-title":"Genome Research"},{"issue":"Suppl. 1","key":"10.1016\/bs.apha.2014.06.003_bb0150","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1007\/s00436-002-0752-y","article-title":"Current chemotherapy of human African trypanosomiasis","volume":"90","author":"Docampo","year":"2003","journal-title":"Parasitology Research"},{"key":"10.1016\/bs.apha.2014.06.003_bb0155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0166-6851(97)00209-0","article-title":"Multiple mechanisms of immune evasion by African trypanosomes","volume":"91","author":"Donelson","year":"1998","journal-title":"Molecular and Biochemical Parasitology"},{"issue":"6","key":"10.1016\/bs.apha.2014.06.003_bb0160","doi-asserted-by":"crossref","first-page":"586","DOI":"10.4269\/ajtmh.1996.55.586","article-title":"The efficacy of pentamidine in the treatment of early-late stage Trypanosoma brucei gambiense trypanosomiasis","volume":"55","author":"Doua","year":"1996","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"2","key":"10.1016\/bs.apha.2014.06.003_bb0165","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0001-706X(92)90054-2","article-title":"Absence of the LiTat 1.3 (CATT antigen) gene in Trypanosoma brucei gambiense stocks from Cameroon","volume":"51","author":"Dukes","year":"1992","journal-title":"Acta Tropica"},{"issue":"9","key":"10.1016\/bs.apha.2014.06.003_bb0170","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1046\/j.1365-3156.1998.00291.x","article-title":"Megazol combined with suramin: A chemotherapy regimen which reversed the CNS pathology in a model of human African trypanosomiasis in mice","volume":"3","author":"Enanga","year":"1998","journal-title":"Tropical Medicine and International Health"},{"issue":"6","key":"10.1016\/bs.apha.2014.06.003_bb0175","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0166-6851(80)90050-X","article-title":"Uptake of the trypanocidal drug suramin by bloodstream forms of Trypanosoma brucei and its effect on respiration and growth rate in vivo","volume":"1","author":"Fairlamb","year":"1980","journal-title":"Molecular and Biochemical Parasitology"},{"issue":"2\u20133","key":"10.1016\/bs.apha.2014.06.003_bb0180","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.mam.2012.10.007","article-title":"The SLC3 and SLC7 families of amino acid transporters","volume":"34","author":"Fotiadis","year":"2013","journal-title":"Molecular Aspects of Medicine"},{"issue":"7289","key":"10.1016\/bs.apha.2014.06.003_bb0185","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nature08893","article-title":"N-myristoyltransferase inhibitors as new leads to treat sleeping sickness","volume":"464","author":"Frearson","year":"2010","journal-title":"Nature"},{"issue":"4","key":"10.1016\/bs.apha.2014.06.003_bb0190","first-page":"411","article-title":"Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human africa trypanosomiasis with natural products (review)","volume":"22","author":"Gehrig","year":"2008","journal-title":"International Journal of Molecular Medicine"},{"issue":"11","key":"10.1016\/bs.apha.2014.06.003_bb0195","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S1471-4922(02)02390-5","article-title":"Will the real Trypanosoma brucei rhodesiense please step forward?","volume":"18","author":"Gibson","year":"2002","journal-title":"Trends in Parasitology"},{"issue":"5","key":"10.1016\/bs.apha.2014.06.003_bb0200","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1080\/13550280802282934","article-title":"Traversal of human and animal trypanosomes across the blood-brain barrier","volume":"14","author":"Grab","year":"2008","journal-title":"Journal of Neurovirology"},{"issue":"9","key":"10.1016\/bs.apha.2014.06.003_bb0205","first-page":"1570","article-title":"Animal experimental investigation into the activity of nifurtimox against Trypanosoma cruzi","volume":"22","author":"Haberkorn","year":"1972","journal-title":"Arzneimittelforschung"},{"issue":"2","key":"10.1016\/bs.apha.2014.06.003_bb0210","doi-asserted-by":"crossref","first-page":"e2704","DOI":"10.1371\/journal.pntd.0002704","article-title":"Incorporating scale dependence in disease burden estimates: The case of human African trypanosomiasis in Uganda","volume":"8","author":"Hackett","year":"2014","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"12","key":"10.1016\/bs.apha.2014.06.003_bb0215","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0166-2236(00)02004-X","article-title":"Molecular physiology and pathophysiology of tight junctions in the blood -brain barrier","volume":"24","author":"Huber","year":"2001","journal-title":"Trends in Neurosciences"},{"issue":"9","key":"10.1016\/bs.apha.2014.06.003_bb0220","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1128\/AAC.41.9.1922","article-title":"Alterations in ornithine decarboxylase characteristics account for tolerance of Trypanosoma brucei rhodesiense to D, L-alpha-difluoromethylornithine","volume":"41","author":"Iten","year":"1997","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"6","key":"10.1016\/bs.apha.2014.06.003_bb0225","doi-asserted-by":"crossref","first-page":"e1691","DOI":"10.1371\/journal.pntd.0001691","article-title":"Untreated human infections by Trypanosoma brucei gambiense are not 100% fatal","volume":"6","author":"Jamonneau","year":"2012","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"2","key":"10.1016\/bs.apha.2014.06.003_bb0230","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1124\/jpet.110.172981","article-title":"The distribution of nifurtimox across the healthy and trypanosome-infected murine blood-brain and blood-cerebrospinal fluid barriers","volume":"336","author":"Jeganathan","year":"2011","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"3\u20134","key":"10.1016\/bs.apha.2014.06.003_bb0235","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0001-706X(93)90093-Q","article-title":"Combination chemotherapy of CNS trypanosomiasis","volume":"54","author":"Jennings","year":"1993","journal-title":"Acta Tropica"},{"issue":"3","key":"10.1016\/bs.apha.2014.06.003_bb0240","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1365-2990.1997.tb01206.x","article-title":"The role of the polyamine inhibitor eflornithine in the neuropathogenesis of experimental murine African trypanosomiasis","volume":"23","author":"Jennings","year":"1997","journal-title":"Neuropathology and Applied Neurobiology"},{"issue":"1\u20132","key":"10.1016\/bs.apha.2014.06.003_bb0245","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0006-8993(00)02758-X","article-title":"The 4F2hc\/LAT1 complex transports l-DOPA across the blood-brain barrier","volume":"879","author":"Kageyama","year":"2000","journal-title":"Brain Research"},{"issue":"4","key":"10.1016\/bs.apha.2014.06.003_bb0250","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1172\/JCI200421052","article-title":"Human African trypanosomiasis of the CNS: Current issues and challenges","volume":"113","author":"Kennedy","year":"2004","journal-title":"Journal of Clinical Investigation"},{"issue":"2","key":"10.1016\/bs.apha.2014.06.003_bb0255","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S1474-4422(12)70296-X","article-title":"Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)","volume":"12","author":"Kennedy","year":"2013","journal-title":"The Lancet Neurology"},{"issue":"7","key":"10.1016\/bs.apha.2014.06.003_bb0260","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s11095-007-9254-z","article-title":"Polyspecific organic cation transporters: Structure, function, physiological roles, and biopharmaceutical implications","volume":"24","author":"Koepsell","year":"2007","journal-title":"Pharmaceutical Research"},{"issue":"12","key":"10.1016\/bs.apha.2014.06.003_bb0265","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1002\/cmdc.201100422","article-title":"New prodrugs of the antiprotozoal drug pentamidine","volume":"6","author":"Kotthaus","year":"2011","journal-title":"ChemMedChem"},{"issue":"2","key":"10.1016\/bs.apha.2014.06.003_bb0270","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pneurobio.2009.12.001","article-title":"African trypanosome infections of the nervous system: Parasite entry and effects on sleep and synaptic functions","volume":"91","author":"Kristensson","year":"2010","journal-title":"Progress in Neurobiology"},{"issue":"10","key":"10.1016\/bs.apha.2014.06.003_bb0275","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2307\/1309990","article-title":"Trypanosomes and hominid evolution","volume":"35","author":"Lambrecht","year":"1985","journal-title":"Bioscience"},{"issue":"12","key":"10.1016\/bs.apha.2014.06.003_bb0280","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S1473-3099(03)00834-X","article-title":"The challenge of Trypanosoma brucei gambiense sleeping sickness diagnosis outside Africa","volume":"3","author":"Lejon","year":"2003","journal-title":"The Lancet Infectious Diseases"},{"key":"10.1016\/bs.apha.2014.06.003_bb0285","first-page":"CD006201","article-title":"Chemotherapy for second-stage human African trypanosomiasis","volume":"8","author":"Lutje","year":"2010","journal-title":"Cochrane Database of Systematic Reviews (Online)"},{"issue":"2","key":"10.1016\/bs.apha.2014.06.003_bb0290","first-page":"106","article-title":"Identification of three ABC transporter genes in Trypanosoma brucei spp","volume":"84","author":"Maser","year":"1998","journal-title":"Parasitology Research"},{"issue":"1\u20132","key":"10.1016\/bs.apha.2014.06.003_bb0295","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.physbeh.2007.05.045","article-title":"Migration of African trypanosomes across the blood-brain barrier","volume":"92","author":"Masocha","year":"2007","journal-title":"Physiology and Behavior"},{"issue":"9","key":"10.1016\/bs.apha.2014.06.003_bb0300","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1286-4579(01)01432-0","article-title":"Drug resistance in Trypanosoma brucei spp., the causative agents of sleeping sickness in man and nagana in cattle","volume":"3","author":"Matovu","year":"2001","journal-title":"Microbes and Infection"},{"issue":"5","key":"10.1016\/bs.apha.2014.06.003_bb0305","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1128\/EC.2.5.1003-1008.2003","article-title":"Mechanisms of arsenical and diamidine uptake and resistance in Trypanosoma brucei","volume":"2","author":"Matovu","year":"2003","journal-title":"Eukaryotic Cell"},{"issue":"2","key":"10.1016\/bs.apha.2014.06.003_bb0310","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1124\/dmd.108.024083","article-title":"Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters","volume":"37","author":"Ming","year":"2009","journal-title":"Drug Metabolism and Disposition"},{"issue":"9","key":"10.1016\/bs.apha.2014.06.003_bb0315","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-3156.2002.00933.x","article-title":"Combination of eflornithine and melarsoprol for melarsoprol-resistant Gambian trypanosomiasis","volume":"7","author":"Mpia","year":"2002","journal-title":"Tropical Medicine and International Health"},{"issue":"2\u20133","key":"10.1016\/bs.apha.2014.06.003_bb0320","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.mam.2012.07.001","article-title":"The SLC2 (GLUT) family of membrane transporters","volume":"34","author":"Mueckler","year":"2013","journal-title":"Molecular Aspects of Medicine"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.003_bb0325","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1046\/j.0305-1846.2001.00306.x","article-title":"Trypanosoma brucei brucei crosses the blood-brain barrier while tight junction proteins are preserved in a rat chronic disease model","volume":"27","author":"Mulenga","year":"2001","journal-title":"Neuropathology and Applied Neurobiology"},{"issue":"10","key":"10.1016\/bs.apha.2014.06.003_bb0330","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1128\/AAC.00498-10","article-title":"Discovery of novel orally bioavailable oxaborole 6-carboxamides that demonstrate cure in a murine model of late-stage central nervous system African trypanosomiasis","volume":"54","author":"Nare","year":"2010","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"7","key":"10.1016\/bs.apha.2014.06.003_bb0335","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2174\/138920010792927325","article-title":"Structure and function of the human breast cancer resistance protein (BCRP\/ABCG2)","volume":"11","author":"Ni","year":"2010","journal-title":"Current Drug Metabolism"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.003_bb0340","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00436-002-0799-9","article-title":"Arsenicals (melarsoprol), pentamidine and suramin in the treatment of human African trypanosomiasis","volume":"90","author":"Nok","year":"2003","journal-title":"Parasitology Research"},{"issue":"12","key":"10.1016\/bs.apha.2014.06.003_bb0345","first-page":"792","article-title":"Duration of symptoms and case fatality of sleeping sickness caused by Trypanosoma brucei rhodesiense in Tororo, Uganda","volume":"74","author":"Odiit","year":"1997","journal-title":"East African Medical Journal"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.003_bb0350","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1021\/mp3004308","article-title":"Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC\/D3 as a human blood-brain barrier model","volume":"10","author":"Ohtsuki","year":"2013","journal-title":"Molecular Pharmaceutics"},{"issue":"6","key":"10.1016\/bs.apha.2014.06.003_bb0355","doi-asserted-by":"crossref","first-page":"E1167","DOI":"10.1152\/ajpendo.00193.2003","article-title":"Na+-dependent transport of large neutral amino acids occurs at the abluminal membrane of the blood-brain barrier","volume":"285","author":"O'Kane","year":"2003","journal-title":"American Journal of Physiology - Endocrinology and Metabolism"},{"issue":"2","key":"10.1016\/bs.apha.2014.06.003_bb0360","doi-asserted-by":"crossref","first-page":"E412","DOI":"10.1152\/ajpendo.00007.2006","article-title":"Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+","volume":"291","author":"O'Kane","year":"2006","journal-title":"American Journal of Physiology. Endocrinology and Metabolism"},{"issue":"2","key":"10.1016\/bs.apha.2014.06.003_bb0365","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0166-6851(02)00096-8","article-title":"Evidence for a non-LDL-mediated entry route for the trypanocidal drug suramin in Trypanosoma brucei","volume":"122","author":"Pal","year":"2002","journal-title":"Molecular and Biochemical Parasitology"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.003_bb0370","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","article-title":"The blood-brain barrier: Bottleneck in brain drug development","volume":"2","author":"Pardridge","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/bs.apha.2014.06.003_bb0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-308X(08)60410-8","article-title":"The treatment of human African trypanosomiasis","volume":"33","author":"Pepin","year":"1994","journal-title":"Advances in Parasitology"},{"issue":"4","key":"10.1016\/bs.apha.2014.06.003_bb0380","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/0035-9203(94)90430-8","article-title":"Gambiense trypanosomiasis: Frequency of, and risk factors for, failure of melarsoprol therapy","volume":"88","author":"P\u00e9pin","year":"1994","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"4","key":"10.1016\/bs.apha.2014.06.003_bb0385","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/0035-9203(89)90270-8","article-title":"An open clinical trial of nifurtimox for arseno-resistant Trypanosoma brucei gambiense sleeping sickness in central Zaire","volume":"83","author":"Pepin","year":"1989","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"6","key":"10.1016\/bs.apha.2014.06.003_bb0390","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1080\/00034983.1994.11812911","article-title":"Blood-brain barrier damage in experimental African trypanosomiasis","volume":"88","author":"Philip","year":"1994","journal-title":"Annals of Tropical Medicine and Parasitology"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.003_bb0395","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.exppara.2007.05.014","article-title":"A multiplex PCR that discriminates between Trypanosoma brucei brucei and zoonotic T. b. rhodesiense","volume":"118","author":"Picozzi","year":"2008","journal-title":"Experimental Parasitology"},{"issue":"7527","key":"10.1016\/bs.apha.2014.06.003_bb0400","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1136\/bmj.331.7527.1238","article-title":"Sleeping sickness in Uganda: A thin line between two fatal diseases","volume":"331","author":"Picozzi","year":"2005","journal-title":"British Medical Journal"},{"issue":"9683","key":"10.1016\/bs.apha.2014.06.003_bb0405","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0140-6736(09)61117-X","article-title":"Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: A multicentre, randomised, phase III, non-inferiority trial","volume":"374","author":"Priotto","year":"2009","journal-title":"The Lancet"},{"issue":"11","key":"10.1016\/bs.apha.2014.06.003_bb0410","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1086\/522982","article-title":"Nifurtimox-eflornithine combination therapy for second-stage Trypanosoma brucei gambiense sleeping sickness: A randomized clinical trial in Congo","volume":"45","author":"Priotto","year":"2007","journal-title":"Clinical Infectious Diseases"},{"issue":"3","key":"10.1016\/bs.apha.2014.06.003_bb0415","doi-asserted-by":"crossref","first-page":"289","DOI":"10.4269\/ajtmh.2002.67.289","article-title":"Novel primer sequences for polymerase chain reaction-based detection of Trypanosoma brucei gambiense","volume":"67","author":"Radwanska","year":"2002","journal-title":"American Journal of Tropical Medicine and Hygiene"},{"issue":"4","key":"10.1016\/bs.apha.2014.06.003_bb0420","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/0035-9203(86)90162-8","article-title":"The trypanocidal effect of drugs in different parts of the brain","volume":"80","author":"Raseroka","year":"1986","journal-title":"Transactions of the Royal Society of Tropical Medicine and Hygiene"},{"issue":"4","key":"10.1016\/bs.apha.2014.06.003_bb0425","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1111\/j.1471-4159.2008.05706.x","article-title":"The blood-brain barrier significantly limits eflornithine entry into Trypanosoma brucei brucei infected mouse brain","volume":"107","author":"Sanderson","year":"2008","journal-title":"Journal of Neurochemistry"},{"issue":"3","key":"10.1016\/bs.apha.2014.06.003_bb0430","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1124\/jpet.108.149872","article-title":"Pentamidine movement across the murine blood-brain and blood-cerebrospinal fluid barriers: Effect of trypanosome infection, combination therapy, P-glycoprotein, and multidrug resistance-associated protein","volume":"329","author":"Sanderson","year":"2009","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"9","key":"10.1016\/bs.apha.2014.06.003_bb0435","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1128\/AAC.00372-07","article-title":"Distribution of suramin, an antitrypanosomal drug, across the blood-brain and blood-cerebrospinal fluid interfaces in wild-type and P-glycoprotein transporter-deficient mice","volume":"51","author":"Sanderson","year":"2007","journal-title":"Antimicrobial Agents and Chemotherapy"},{"issue":"5","key":"10.1016\/bs.apha.2014.06.003_bb0440","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1093\/clinids\/7.5.625","article-title":"Pentamidine: A review","volume":"7","author":"Sands","year":"1985","journal-title":"Reviews of Infectious Diseases"},{"issue":"2","key":"10.1016\/bs.apha.2014.06.003_bb0445","doi-asserted-by":"crossref","first-page":"e1007","DOI":"10.1371\/journal.pntd.0001007","article-title":"The human African trypanosomiasis control and surveillance programme of the world health organization 2000\u20132009: The way forward","volume":"5","author":"Simarro","year":"2011","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"3","key":"10.1016\/bs.apha.2014.06.003_bb0450","article-title":"The history of African trypanosomiasis","volume":"1","author":"Steverding","year":"2008","journal-title":"Parasites and Vectors"},{"issue":"2","key":"10.1016\/bs.apha.2014.06.003_bb0455","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.actatropica.2004.03.010","article-title":"Distribution and quantitation of the anti-trypanosomal diamidine 2,5-bis(4-amidinophenyl)furan (DB75) and its N-methoxy prodrug DB289 in murine brain tissue","volume":"91","author":"Sturk","year":"2004","journal-title":"Acta Tropica"},{"issue":"5","key":"10.1016\/bs.apha.2014.06.003_bb0460","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1093\/nar\/gkm1180","article-title":"Pentamidine binds to tRNA through non-specific hydrophobic interactions and inhibits aminoacylation and translation","volume":"36","author":"Sun","year":"2008","journal-title":"Nucleic Acids Research"},{"issue":"3","key":"10.1016\/bs.apha.2014.06.003_bb0465","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1021\/jm401178t","article-title":"Substituted 2-phenylimidazopyridines: A new class of drug leads for human African trypanosomiasis","volume":"57","author":"Tatipaka","year":"2014","journal-title":"Journal of Medicinal Chemistry"},{"issue":"6","key":"10.1016\/bs.apha.2014.06.003_bb0470","doi-asserted-by":"crossref","first-page":"e2230","DOI":"10.1371\/journal.pntd.0002230","article-title":"Safety, pharmacokinetic, and efficacy studies of oral DB868 in a first stage vervet monkey model of human African trypanosomiasis","volume":"7","author":"Thuita","year":"2013","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"12","key":"10.1016\/bs.apha.2014.06.003_bb0475","doi-asserted-by":"crossref","first-page":"e923","DOI":"10.1371\/journal.pntd.0000923","article-title":"Fexinidazole\u2014A new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness","volume":"4","author":"Torreele","year":"2010","journal-title":"PLoS Neglected Tropical Diseases"},{"issue":"11","key":"10.1016\/bs.apha.2014.06.003_bb0480","first-page":"882","article-title":"Evaluation of the micro-CATT, CATT\/Trypanosoma brucei gambiense, and LATEX\/T.b. gambiense methods for serodiagnosis and surveillance of human African trypanosomiasis in west and central Africa","volume":"80","author":"Truc","year":"2002","journal-title":"Bulletin of the World Health Organization"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.003_bb0485","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1574-6968.1997.tb10486.x","article-title":"The rate of antigenic variation in fly-transmitted and syringe-passaged infections of Trypanosoma brucei","volume":"153","author":"Turner","year":"1997","journal-title":"FEMS Microbiology Letters"},{"issue":"2","key":"10.1016\/bs.apha.2014.06.003_bb0490","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1471-4159.2011.07208.x","article-title":"Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors","volume":"117","author":"Uchida","year":"2011","journal-title":"Journal of Neurochemistry"},{"issue":"6","key":"10.1016\/bs.apha.2014.06.003_bb0495","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/S0092-8674(00)81706-7","article-title":"A VSG expression site-associated gene confers resistance to human serum in Trypanosoma rhodesiense","volume":"95","author":"Van Xong","year":"1998","journal-title":"Cell"},{"issue":"11","key":"10.1016\/bs.apha.2014.06.003_bb0500","doi-asserted-by":"crossref","first-page":"e1001204","DOI":"10.1371\/journal.ppat.1001204","article-title":"A molecular mechanism for eflornithine resistance in African trypanosomes","volume":"6","author":"Vincent","year":"2010","journal-title":"PLoS Pathogens"},{"key":"10.1016\/bs.apha.2014.06.003_bb0505","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.pa.35.040195.000521","article-title":"Molecular mechanisms and therapeutic approaches to the treatment of African trypanosomiasis","volume":"35","author":"Wang","year":"1995","journal-title":"Annual Review of Pharmacology and Toxicology"},{"key":"10.1016\/bs.apha.2014.06.003_bb0510","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.brainres.2011.11.053","article-title":"The transport of nifurtimox, an anti-trypanosomal drug, in an in vitro model of the human blood-brain barrier: Evidence for involvement of breast cancer resistance protein","volume":"1436","author":"Watson","year":"2012","journal-title":"Brain Research"},{"issue":"11","key":"10.1016\/bs.apha.2014.06.003_bb0515","doi-asserted-by":"crossref","first-page":"5330","DOI":"10.1128\/AAC.00398-13","article-title":"Pharmacokinetics, Trypanosoma brucei gambiense efficacy, and time of drug action of DB829, a preclinical candidate for treatment of second-stage human African trypanosomiasis","volume":"57","author":"Wenzler","year":"2013","journal-title":"Antimicrobial Agents and Chemotherapy"},{"key":"10.1016\/bs.apha.2014.06.003_bb9000","unstructured":"WHO Expert Committee on human African trypanosomiasis (2013) Control and surveillance of human African trypanosomiasis. WHO Technical Report Series, Volume 984, Geneva: World Health Organization Press. Published at http:\/\/apps.who.int\/iris\/bitstream\/10665\/95732\/1\/9789241209847_eng.pdf and last accessed on January 30th, 2014"},{"issue":"1","key":"10.1016\/bs.apha.2014.06.003_bb0520","doi-asserted-by":"crossref","first-page":"113","DOI":"10.55782\/ane-2011-1828","article-title":"In vitro models of the blood-brain barrier","volume":"71","author":"Wilhelm","year":"2011","journal-title":"Acta Neurobiologiae Experimentalis"},{"issue":"3","key":"10.1016\/bs.apha.2014.06.003_bb0525","doi-asserted-by":"crossref","first-page":"e34304","DOI":"10.1371\/journal.pone.0034304","article-title":"Late stage infection in sleeping sickness","volume":"7","author":"Wolburg","year":"2012","journal-title":"PLoS One"}],"container-title":["Advances in Pharmacology","Pharmacology of the Blood Brain Barrier: Targeting CNS Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358914000040?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1054358914000040?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T20:06:42Z","timestamp":1717272402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1054358914000040"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"ISBN":["9780128002827"],"references-count":106,"URL":"https:\/\/doi.org\/10.1016\/bs.apha.2014.06.003","relation":{},"ISSN":["1054-3589"],"issn-type":[{"value":"1054-3589","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}